174 master-"https:" "https:" "https:" "https:" "UCL" positions at University College Cork
Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
project. TRACER investigates the potential role of CT perfusion imaging in evaluating immunotherapy treatment response in lung cancer. The research will be carried out under the supervision of Principal
-
: 48 Months, Full-Time Post Salary: €46,805 - €53,391 p.a. (IUA PD1 Salary Scale) For an information package including further details of the post see https://ore.ucc.ie/ Informal enquiries can be made
-
• Apply with your CV through https://ore.ucc.ie/, Type the job ID into the keywords section and the role will come up. • Ability to start as soon as possible. Project Title: UCC Cancer Trials Group
-
an information package including further details of the post see https://ore.ucc.ie/ Informal enquiries can be made in confidence to Prof Geraldine Boylan, Director of UCC Futures - Children
-
essential. Project Title: Newborn Brain Test Post Duration: 12 Months Salary: €77,500 gross p.a. Personal Rate (pro rata 0.8 FTE) For an information package including further details of the post see https
-
Duration: 1 Year 9 Months, Part-Time Post Salary: €46,805 - €53,391 p.a. pro rata .8 FTE (IUA PD1 Salary Scale) For an information package including further details of the post see https://ore.ucc.ie
-
police clearance check may form part of the selection process. For an information package including full details of the post, selection criteria and application process see https://ore.ucc.ie
-
the Sustainability Institute. Reporting to the Chief Commercial Officer, the post-holder will ensure the provision of a comprehensive and professional administrative support service within the Sustainability Institute
-
details of the post, selection criteria and application process see https://ore.ucc.ie/. The University, at its discretion, may undertake to make an additional appointment(s) from this competition
-
will be carried out under the supervision of Principal Investigator Dr. Andrew England and Chief Investigator Professor Michael Maher. We welcome applications from researchers with an established